Reduction of oxidative storage lesion for red cells using Hemanext system in clinical trial in hematology patients.
Improved platelet products for hemotherapy of HLA-alloimmunized, platelet-refractory patients: platelets made HLA class I deficient by acid treatment.
Freeze-drying of platelets for treatment of difficult diabetic wounds.
Examination of new phthalate-free filters and plastics for blood products. Immunomodulating effects of the mushroom extract, AndosanTM, in asthma patients and monitoring with a novel mast cell activation test for allergens.
Anti-COVID-19 effect of AndosanTM in cell cultures.
Haugen M, Magnussen K, Aarsland TE, Nissen-Meyer LSH, Strand TA(2024) The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial Trials, 25(1), 175 DOI 10.1186/s13063-024-08035-7, PubMed 38468338
Hetland G, Fagerhol MK, Mirlashari MR, Nissen-Meyer LSH, Croci S, Lonati PA, Bonacini M, Salvarani C, Marvisi C, Bodio C, Muratore F, Borghi MO, Meroni PL(2024) Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy Biomedicines, 12(4) DOI 10.3390/biomedicines12040766, PubMed 38672123
Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G(2023) DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors Scand J Immunol, 98(1), e13274 DOI 10.1111/sji.13274, PubMed 37676118
Get in touch
Contact
Group Leader Lise Sofie Haug Nissen-Meyer Department of immunology and transfusion medicine Tel: +47 +22117828 / 48284525 E-mail: lisoha@ous-hf.no